KARYOPHARM THERAPE earnings per share and revenue

25K earnings per share for the last quarter are -0.22 CHF whereas the estimation was -0.22 CHF which accounts for 1.09% surprise. Company revenue for the same period amounts to 32.87 M CHF despite the estimated figure of 32.14 M CHF. Estimated earnings per share for the next quarter are -0.22 CHF, and revenue is expected to reach 33.33 M CHF. Also watch annual changes over time to get a bigger picture of 25K earnings per share and revenue dynamics.